{
    "nct_id": "NCT01955161",
    "title": "Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil",
    "status": "COMPLETED",
    "last_update_time": "2017-08-22",
    "description_brief": "To establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).",
    "description_detailed": "The study consisted of a screening period (up to 2-week period from screening to randomization), a 24-week double-blind treatment period with placebo or idalopirdine 30 mg/day or 60 mg/day as adjunctive therapy to donepezil 10 mg/day, and a 4-week safety follow-up period following study completion or withdrawal from treatment.",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "FG001",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "FG002",
                    "title": "Idalopirdine 60 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "310"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "313"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "310"
                                }
                            ]
                        },
                        {
                            "type": "Treated",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "308"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "313"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "309"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "283"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "288"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "275"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "27"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "25"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "35"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal before treatment",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "14"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "15"
                                }
                            ]
                        },
                        {
                            "type": "Death",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "3"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "9"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "8"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "12"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: physician decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: disallowed medication",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: caregiver unavailable",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: moved to nursing home",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: insufficient compliance",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: primary biliary cirrhosis",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other reason: patient's will",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "A total of 933 patients were randomized into the study but 3 patients were not treated (did not receive IMP). The baseline analysis population only consist of patients who have been treated.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "BG001",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "BG002",
                    "title": "Idalopirdine 60 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "BG003",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "308"
                        },
                        {
                            "groupId": "BG001",
                            "value": "313"
                        },
                        {
                            "groupId": "BG002",
                            "value": "309"
                        },
                        {
                            "groupId": "BG003",
                            "value": "930"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "73.8",
                                            "spread": "8.0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "74.0",
                                            "spread": "8.8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "73.7",
                                            "spread": "8.6"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "73.8",
                                            "spread": "8.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "198"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "208"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "201"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "607"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "110"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "105"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "108"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "323"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "4"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "41"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "125"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "266"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "268"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "267"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "801"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "5"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "8"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "283"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "287"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "284"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "854"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "60"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Argentina",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "70"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Romania",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Czech Republic",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "36"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "109"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "45"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "130"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ukraine",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "61"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Spain",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "60"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Canada",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "40"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Belgium",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "18"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Denmark",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "13"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Poland",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "73"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Italy",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "South Africa",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "57"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Bulgaria",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "60"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Chile",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "28"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "31"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "89"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "France",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "14"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Germany",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "58"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE total score at screening",
                    "description": "The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17.4",
                                            "spread": "2.9"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17.2",
                                            "spread": "3.1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17.4",
                                            "spread": "2.9"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "17.4",
                                            "spread": "3.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in Cognition",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) total score.\n\nThe Alzheimer's Disease Assessment Scale - Cognitive subscale (ADAS-cog) is a 11-item neuropsychological test that assess the severity of cognitive impairment. The items determine the patient's orientation, memory, language, and praxis. Total score of the 11 items range from 0 to 70 (lower score indicates lower cognitive impairment).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "304"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "310"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "308"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.13",
                                            "spread": "0.35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.47",
                                            "spread": "0.35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.18",
                                            "spread": "0.35"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.9591",
                            "pValueComment": "Corrected for multiplicity",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.33",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.59",
                            "ciUpperLimit": "1.26",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.47",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.05",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.88",
                            "ciUpperLimit": "0.98",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.47",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Daily Functioning",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL23) total score.\n\nThe Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL23) is a 23-item clinician-rated inventory to assess activities of daily living (conducted with a caregiver or informant). Each item comprises a series of hierarchical sub-questions, ranging from the highest level of independent performance to a complete loss for each activity. Total score of the 23 items ranges from 0 to 78 (higher score indicates lower disability).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "304"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "310"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "308"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.03",
                                            "spread": "0.49"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.12",
                                            "spread": "0.48"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-2.02",
                                            "spread": "0.49"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according toe the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.08",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.37",
                            "ciUpperLimit": "1.21",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.66",
                            "estimateComment": "A positive mean difference indicates a treatment effect in favour of idalopirdine."
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.01",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.29",
                            "ciUpperLimit": "1.31",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.66",
                            "estimateComment": "A positive mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Global Impression",
                    "description": "Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change (ADCS-CGIC) score at Week 24.\n\nThe Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change is a semi-structured interview to assess clinically relevant changes in patients with AD. The items determine cognition, behavior, social and daily functioning. Severity at baseline is rated on a 7-point scale from 1 (normal, not ill at all) to 7 (among the most extremely ill patients). The clinically relevant change from baseline is rated on a 7-point scale from 1 (marked improvement) to 7 (marked worsening).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "303"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "309"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "307"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.29",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.32",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4.13",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.03",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.15",
                            "ciUpperLimit": "0.20",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.09",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG002"
                            ],
                            "groupDescription": "For demonstrating efficacy of a dose, ADAS-cog total score and either ADCS-ADL23 total score or ADCS CGIC had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for each dose at significance level 2.5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "1.000",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Treatment, country, MMSE stratum, week as fixed effects, baseline score, treatment-by-week, MMSE stratum-by-week, and baseline-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.16",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.34",
                            "ciUpperLimit": "0.02",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.09",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favour of idalopirdine."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Behavioural Disturbance",
                    "description": "Change from baseline to Week 24 in Neuropsychiatric Inventory (NPI) total score.\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total NPI score is the frequency ratings multiplied by the severity ratings and ranges from 0 to 144 (higher score indicates worse outcome).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "304"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "310"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "308"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.21",
                                            "spread": "0.62"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.21",
                                            "spread": "0.62"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.39",
                                            "spread": "0.63"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Individual Behavioural Disturbance Items",
                    "description": "Change in single NPI item scores at Week 24.\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). Total score for each single NPI item ranges from 0-12 (frequency multiplied by severity), where higher scores represent worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure/item assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "304"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "310"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "308"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Delusions",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.11",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.04",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.01",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hallucinations",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.13",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.03",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.03",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Agitation/aggression",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.01",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.04",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.10",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Depression/dysphoria",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.02",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.08",
                                            "spread": "0.10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Anxiety",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.02",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.13",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.13",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Elation/euphoria",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.09",
                                            "spread": "0.05"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.03",
                                            "spread": "0.05"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.03",
                                            "spread": "0.05"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Apathy/indifference",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.18",
                                            "spread": "0.15"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.23",
                                            "spread": "0.15"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.27",
                                            "spread": "0.15"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Disinhibition",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.05",
                                            "spread": "0.08"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "spread": "0.08"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.01",
                                            "spread": "0.08"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Irritability/lability",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.14",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.02",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.00",
                                            "spread": "0.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Aberrant motor behaviour",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.33",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.13",
                                            "spread": "0.13"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sleep",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "308"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.01",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.03",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Appetite/eating disorder",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "304"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "310"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "308"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.08",
                                            "spread": "0.13"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.14",
                                            "spread": "0.13"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-0.04",
                                            "spread": "0.13"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in NPI Anxiety Item Score in Patients With an NPI Anxiety Item Score of at Least 2 at Baseline",
                    "description": "Change from baseline to Week 24 in NPI anxiety item score in patients with an NPI anxiety item score of at least 2 at baseline\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total score for the NPI anxiety item ranges from 0-12 (frequency multiplied by severity), where a higher score represents a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome/item measure assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "88"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "83"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "76"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.12",
                                            "spread": "0.30"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.56",
                                            "spread": "0.30"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-1.64",
                                            "spread": "0.32"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Improvement",
                    "description": "Clinical response at Week 24 (based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog below or equal to -4, change in ADCS-ADL23 at least 0, and ADCS-CGIC below or equal to 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "calculatePct": false,
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "284"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "290"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "278"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "34"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "27"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Worsening",
                    "description": "Clinical worsening at Week 24 (Based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog above or equal to 4, change in ADCS-ADL23 below 0, and ADCS-CGIC above 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "calculatePct": false,
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "284"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "290"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "278"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "33"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Aspects of Mental Function",
                    "description": "Change from baseline to Week 24 in Mini Mental State Examination (MMSE). The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "282"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "288"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "274"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.06",
                                            "spread": "0.16"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.27",
                                            "spread": "0.16"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.27",
                                            "spread": "0.17"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D) Utility Score",
                    "description": "Change from baseline to Week 24 in EuroQol 5-dimensional (EQ-5D) utility score\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). Each descriptive item is rated on a 3-point index ranging from 1 (no problems) to 3 (extreme problems) that is used for calculating a single summary index (from 0 to 1). A higher EQ-5D score indicates a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "301"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "306"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "304"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.01",
                                            "spread": "0.01"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "spread": "0.01"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.00",
                                            "spread": "0.01"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D VAS)",
                    "description": "Change from baseline to Week 24 in EQ-5D Visual Analogue Scale (EQ-5D VAS).\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). The VAS ranges from 0 (worst imaginable health state) to 100 (best imaginable health state).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least on valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to 10 mg Donepezil\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 30 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        },
                        {
                            "id": "OG002",
                            "title": "Idalopirdine 60 mg",
                            "description": "Idalopirdine adjunct to 10 mg Donepezil\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "301"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "307"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "304"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.40",
                                            "spread": "1.01"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.12",
                                            "spread": "1.01"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.34",
                                            "spread": "1.03"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Baseline to end of study at Week 24",
            "description": "Treatment-Emergent Adverse Events are reported in this section",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to 10 mg Donepezil",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 308,
                    "seriousNumAffected": 12,
                    "seriousNumAtRisk": 308,
                    "otherNumAffected": 39,
                    "otherNumAtRisk": 308
                },
                {
                    "id": "EG001",
                    "title": "Idalopirdine 30 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donezepil",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 313,
                    "seriousNumAffected": 18,
                    "seriousNumAtRisk": 313,
                    "otherNumAffected": 56,
                    "otherNumAtRisk": 313
                },
                {
                    "id": "EG002",
                    "title": "Idalopirdine 60 mg",
                    "description": "Idalopirdine adjunct to 10 mg Donezepil",
                    "deathsNumAffected": 3,
                    "deathsNumAtRisk": 309,
                    "seriousNumAffected": 20,
                    "seriousNumAtRisk": 309,
                    "otherNumAffected": 49,
                    "otherNumAtRisk": 309
                }
            ],
            "seriousEvents": [
                {
                    "term": "Anaemia",
                    "organSystem": "Blood and lymphatic system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Acute myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Angina pectoris",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Atrial fibrillation",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Coronary artery disease",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Sinus node dysfunction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Gastrooesophageal reflux disease",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Pancreatitis acute",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Sudden death",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Appendicitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Bacterial diarrhoea",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Bacterial sepsis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Gastroenteritis viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Influenza",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Pneumonia bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Respiratory tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Femoral neck fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Head injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Hip fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Radius fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Wrist fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Alanine aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Aspartate aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Bilirubin conjugated increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Blood alkaline phosphatase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Blood bilirubin increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "C-reactive protein increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Gamma-glutamyltransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Spinal pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Basal cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Metastases to peritoneum",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Cerebral arteriosclerosis",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Cerebral haematoma",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Cerebral ischaemia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Dementia alzheimer's type",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Presyncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Transient ischaemic attack",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Confusional state",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Delirium",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Impulse-control disorder",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Calculus bladder",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Metrorrhagia",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 198
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 208
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 201
                        }
                    ]
                },
                {
                    "term": "Vaginal fistula",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 198
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 208
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 201
                        }
                    ]
                },
                {
                    "term": "Chronic obstructive pulmonary disease",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Dyspnoea",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Colostomy closure",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Rehabilitation therapy",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Deep vein thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Peripheral artery thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 309
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Accidental overdose",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 27,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 27,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 16,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 15,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 16,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 19,
                            "numAtRisk": 309
                        }
                    ]
                },
                {
                    "term": "Gamma-glutamyltransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 308
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 17,
                            "numAtRisk": 313
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 15,
                            "numAtRisk": 309
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Email contact via",
                "organization": "H. Lundbeck A/S",
                "email": "LundbeckClinicalTrials@lundbeck.com",
                "phone": "+4536301311"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "Idalopirdine (Lu AE58054) \u2014 selective 5\u2011HT6 receptor antagonist (small molecule)",
        "Donepezil \u2014 acetylcholinesterase inhibitor (background therapy)"
    ],
    "placebo": [
        "Placebo (adjunct comparator)"
    ],
    "explanation_target": [
        "Reason: The trial tests idalopirdine as an adjunct to donepezil for symptomatic treatment of mild-to-moderate Alzheimer\u2019s disease. Idalopirdine is a small\u2011molecule, selective 5\u2011HT6 (serotonin) receptor antagonist developed to improve cognition (symptomatic/cognitive enhancement), not to directly target amyloid or tau pathology. \ue200cite\ue202turn0search5\ue202turn0search0\ue201",
        "Act: Extracted trial details \u2014 intervention = idalopirdine (Lu AE58054) added to donepezil; comparator = placebo; intended effect = symptomatic cognitive improvement in mild-to-moderate AD. Phase II reported cognitive benefit when added to donepezil, while the subsequent large Phase III program (multiple 24\u2011week, fixed\u2011dose studies) did not demonstrate consistent efficacy. \ue200cite\ue202turn0search0\ue202turn0search2\ue202turn0search1\ue201",
        "Reflect: Classification check \u2014 according to the provided category definitions, idalopirdine is a small\u2011molecule aimed at improving cognition (a symptomatic/cognitive enhancer) rather than a biologic or a small molecule that targets core Alzheimer pathology; therefore the correct category is 'cognitive enhancer'. No meaningful ambiguity in the description that would point to disease\u2011modifying intent or neuropsychiatric symptom targeting. \ue200cite\ue202turn0search5\ue202turn0search2\ue201",
        "Web search results used (key sources): Lancet Neurology Phase II report of idalopirdine showing cognitive benefit as adjunct to donepezil; pharmacology papers showing high\u2011affinity selective 5\u2011HT6 antagonism and effects on monoamines; summaries and publications reporting the Phase III STAR/STARSHINE program and subsequent negative Phase III findings. \ue200cite\ue202turn0search0\ue202turn0search5\ue202turn0search2\ue202turn0search1\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The investigational drug idalopirdine (Lu AE58054) is a selective antagonist of the serotonin 5\u2011HT6 receptor \u2014 a neurotransmitter (serotonin) receptor implicated in cognition \u2014 and was tested as an adjunctive symptomatic/cognitive enhancer to donepezil rather than as an anti-amyloid or anti-tau disease\u2011modifying agent. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Act: Extracted details from the trial description and literature: intervention = idalopirdine (selective 5\u2011HT6 antagonist) added to background donepezil (an acetylcholinesterase inhibitor) with the intended effect of symptomatic cognitive improvement in mild\u2013moderate AD. Phase II (LADDER) reported cognitive benefit when added to donepezil, while the larger Phase III STAR program failed to demonstrate consistent efficacy. Based on these facts, the most specific CADRO match is D) Neurotransmitter Receptors. \ue200cite\ue202turn1search3\ue202turn1search8\ue202turn1search4\ue201",
        "Reflect: Verification \u2014 5\u2011HT6 is a serotonin (5\u2011HT) receptor, which falls squarely under the CADRO category for neurotransmitter receptors (D). The trial tests a symptomatic cognitive enhancer acting via a neurotransmitter receptor rather than targeting amyloid, tau, inflammation, synaptic growth factors, or other CADRO categories; therefore D) Neurotransmitter Receptors is the appropriate classification. Key supporting web sources are listed below. \ue200cite\ue202turn0search6\ue202turn0search5\ue201",
        "Web search results (key sources cited above):",
        "- Pharmacology and mechanism: idalopirdine is a high\u2011affinity selective 5\u2011HT6 (serotonin) receptor antagonist; preclinical work shows effects on monoamines/glutamate relevant to cognition. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "- Phase II clinical evidence: LADDER (Lancet Neurology / PubMed) reported cognitive improvement when idalopirdine (90 mg/day) was added to donepezil in moderate AD. \ue200cite\ue202turn1search0\ue202turn1search3\ue201",
        "- Phase III outcomes: The STAR/STARSHINE/STARBEAM program (large Phase III studies) did not meet prespecified efficacy endpoints; the phase III program failed to replicate the phase II benefit. \ue200cite\ue202turn1search4\ue202turn1search6\ue201"
    ]
}